Rethinking Anticoagulation in ECMO
Tianyu Zhang and colleagues recently published a systematic review and meta-analysis in Frontiers in Medicine evaluating reduced-intensity and heparin-sparing anticoagulation strategies during Extracorporeal Membrane Oxygenation (ECMO). Systemic anticoagulation with unfractionated heparin has traditionally represented the standard of care in ECMO management; however, bleeding complications continue to pose a significant challenge. The study aimed to determine…
Read
FDA Approves Aficamten (Myqorzo) for Symptomatic Obstructive Hypertrophic Cardiomyopathy
The U.S. Food and Drug Administration (FDA) has approved Myqorzo® (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), denoting a major advancement in targeted pharmacologic management of this complex structural heart disease. Obstructive hypertrophic cardiomyopathy is a genetic myocardial disorder characterized by pathologic thickening of the ventricular myocardium, most notably involving…
Read
Myocardial Microcirculation Combined With Lactate Predicts LV Function After DCD Heart Transplantation
Assessment of donation after circulatory death (DCD) hearts during ex vivo blood perfusion (EVBP) has customarily relied heavily on lactate trends to guide transplantability decisions. However, concerns have been raised regarding whether lactate alone adequately reflects myocardial viability. In a recent experimental study, Saemann et al. (2026) and Colleagues evaluated whether combining myocardial microcirculatory assessment…
Read
Clinical News
Perfusion Times provides news on innovative technologies from everything to clinical trials to how to use and process medical data. We provide information and insights on innovation between clinical trial management and best practices for patient care.
-
Rethinking Anticoagulation in ECMO
-
Myocardial Microcirculation Combined With Lactate Predicts LV Function After DCD Heart Transplantation
-
Normothermic Regional Perfusion as a Platform for DCD Lung Assessment and Recovery
-
Optimizing CO₂ Levels in Acute Brain Injury: Balancing Cerebral Blood Flow and Intracranial Pressure
-
Can a Simple Index Predict Kidney Injury After Heart Surgery in Diabetic Patients?
Medical Device Industry News
Perfusion Times is your direct source for information on the latest medical device products, covering everything involved in the supply chain from biomaterials and materials solutions to electronic devices, medical packaging, motors, and more!
-
AngioVac-Assisted Debulking before Lead Extraction in Device-Related Endocarditis
-
New Cardiac Assist Technology Proven Accurate Through Advanced Simulation
-
FDA Recognizes SeaStar Medical’s SCD as Breakthrough Device for Managing Systemic Inflammation
-
Evaluating Cannula Performance in Pediatric ECMO: Pulsatile vs. Non-Pulsatile Flow Insights
-
Renal Transplant Perfusion through Strategic Patient Positioning
FDA Announcements
Perfusion Times provides up-to-date FDA news releases related to perfusion to ensure you’re educated to follow regulatory requirements in your practice.
-
FDA Approves Aficamten (Myqorzo) for Symptomatic Obstructive Hypertrophic Cardiomyopathy
-
Robotic-Assisted Mitral and Revascularization Procedures: Expanded FDA Clearance for da Vinci 5
-
FDA Expands Indication for Medtronic Evolut™ TAVR Systems
-
BiVACOR’s Total Artificial Heart Earns FDA Breakthrough Status
-
A Wearable Lifeline: FDA Clears Jewel Patch Defibrillator for At-Risk Patients
Healthcare & Economics
Perfusion Times provides best practices on information such as patient charting, data analysis, inventory entry, and more! This also covers managing planning, reporting and analytics to ensure you always have up to date information to care for and have better patient outcomes. Some of the specific topics we cover include cardiopulmonary bypass and support services, autotransfusion and platelet gel services, extracorporeal membrane oxygenation (ECMO) services, chemoperfusion, and database management and legal and professional consultation.
-
Perspectives on Acute Decompensated RV Failure in Pulmonary Arterial Hypertension
-
The Influence of Cardiopulmonary Bypass Duration on Mortality and Mid-Term Survival in Acute Type A Aortic Dissection Repair
-
Advances and Clinical Insights in Cardiac Surgery 2024: A Comprehensive Review of Evidence and Outcomes
-
Study Confirms No Brain Activity During TA-NRP with Supra-Aortic Vessel Ligation
-
Perfusion Optimization and Lactate Dynamics in Normothermic Regional Perfusion A Summary of the 2025 Baylor Experience